Said Zamani-Kord

Statistics

Publications

Citations

262

H-Index

Active since

2005

Affiliations

Neurocrine Biosciences (United States)(Current)

Said Zamani-Kord is an author at Neurocrine Biosciences (United States) specializing in pharmacology, pharmacological treatment of insomnia, and insomnia management.

Publications per year

2005–2010

Publications

Characterization of Novel Selective H<sub>1</sub>-Antihistamines for Clinical Evaluation in the Treatment of Insomnia

Wilna J. Moree, Bin-Feng Li, Florence Jovic et al. · Journal of Medicinal Chemistry · 2009 · 79 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Design and Synthesis of Tricyclic Corticotropin-Releasing Factor-1 Antagonists

Raymond S. Gross, Zhiqiang Guo, Brian Dyck et al. · Journal of Medicinal Chemistry · 2005 · 46 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The discovery and structure–activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia

Karine Lavrador-Erb, Jinghua Yu, Said Zamani-Kord et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Design and Synthesis of Tricyclic Imidazo[4,5- <i>b</i> ]pyridin-2-ones as Corticotropin-Releasing Factor-1 Antagonists

Zhiqiang Guo, John E. Tellew, Raymond S. Gross et al. · Journal of Medicinal Chemistry · 2005 · 27 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

Brain-penetrating 2-aminobenzimidazole H1-antihistamines for the treatment of insomnia

Timothy Coon, Wilna J. Moree, Binfeng Li et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

1–5 of 8